| 101 |
12492115 | Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. | 2002 Aug |
1 |
| 102 |
11259608 | Is cisplatin-induced cell death always produced by apoptosis? | 2001 Apr |
1 |
| 103 |
11313940 | A role for mismatch repair in control of DNA ploidy following DNA damage. | 2001 Apr 5 |
2 |
| 104 |
10673721 | Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha. | 2000 Jan |
1 |
| 105 |
10779360 | p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. | 2000 May |
1 |
| 106 |
10918614 | The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs. | 2000 Jul 20 |
1 |
| 107 |
10936175 | Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. | 2000 Sep |
4 |
| 108 |
10958792 | Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. | 2000 Nov 17 |
8 |
| 109 |
11156413 | Derivation and initial characterization of a mouse mammary tumor cell line carrying the polyomavirus middle T antigen: utility in the development of novel cancer therapeutics. | 2000 Dec 15 |
1 |
| 110 |
10339661 | Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells. | 1999 Jun |
1 |
| 111 |
10404639 | Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin. | 1999 Jun |
6 |
| 112 |
9600935 | p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. | 1998 May 26 |
7 |
| 113 |
9713515 | Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer. | 1998 Jul-Aug |
1 |
| 114 |
9738462 | p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment. | 1998 Aug 28 |
2 |
| 115 |
10200488 | Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance. | 1998 May |
1 |
| 116 |
8673929 | Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. | 1996 Jul |
1 |
| 117 |
8967975 | Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. | 1996 Dec |
2 |
| 118 |
8997395 | The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. | 1996 Dec |
3 |
| 119 |
9042210 | Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53. | 1996 Nov-Dec |
1 |
| 120 |
7651731 | Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants. | 1995 Aug 17 |
2 |
| 121 |
7761100 | MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. | 1995 May 18 |
2 |